Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
16,150 JPY | +0.53% | +4.06% | +20.95% |
Nov. 29 | Interim dividend | FA |
Oct. 12 | Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores | MT |
Sales 2024 * | 942B 6.4B | Sales 2025 * | 1,021B 6.93B | Capitalization | 636B 4.32B |
---|---|---|---|---|---|
Net income 2024 * | 24.66B 167M | Net income 2025 * | 26.75B 182M | EV / Sales 2024 * | 0,65x |
Net cash position 2024 * | 27.03B 184M | Net cash position 2025 * | 31.54B 214M | EV / Sales 2025 * | 0,59x |
P/E ratio 2024 * | 25,8x | P/E ratio 2025 * | 23,8x | Employees | - |
Yield 2024 * | 0,76% | Yield 2025 * | 0,85% | Free-Float | 47.5% |
More Fundamentals
* Assessed data
More news
More news
1 day | +1.58% | ||
1 week | +3.78% | ||
Current month | +2.65% | ||
1 month | +1.68% | ||
3 months | -6.24% | ||
6 months | +16.24% | ||
Current year | +20.43% |
1 week
15 415.00
16 070.00

1 month
15 180.00
16 160.00

Current year
11 430.00
17 440.00

1 year
11 430.00
17 440.00

3 years
10 770.00
20 700.00

5 years
8 425.00
20 700.00

10 years
5 040.00
20 700.00

Managers | Title | Age | Since |
---|---|---|---|
Hideaki Yokoyama
PSD | President | 43 | 2003 |
Motoi Takemori
DFI | Director of Finance/CFO | 58 | 1994 |
Taku Moriguchi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yukitaka Uno
BRD | Director/Board Member | 50 | 2005 |
Futoshi Shibata
BRD | Director/Board Member | 52 | 1998 |
Motoi Takemori
DFI | Director of Finance/CFO | 58 | 1994 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.19% | 4 M€ | +15.93% | ||
0.80% | 339 M€ | +8.46% | ||
0.33% | 100 M€ | +7.03% | ||
0.29% | 228 M€ | -.--% | - | |
0.13% | 47 M€ | +24.76% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-04 | 16,150 | +0.53% | 78 700 |
23-12-04 | 16,065 | +1.58% | 218,300 |
23-12-01 | 15,815 | +1.05% | 136,600 |
23-11-30 | 15,650 | -1.07% | 187,100 |
23-11-29 | 15,820 | +2.03% | 497,800 |
Delayed Quote Japan Exchange, December 04, 2023 at 01:00 am EST
More quotes
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.
Sector
Drug Retailers
Calendar
2024-01-11
- Q2 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
D+
Sell
Buy

Mean consensus
HOLD
Number of Analysts
11
Last Close Price
16,065JPY
Average target price
16,533.64JPY
Spread / Average Target
+2.92%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.43% | 4 254 M $ | |
+19.95% | 4 058 M $ | |
+15.50% | 3 569 M $ | |
+8.11% | 2 609 M $ | |
-25.48% | 2 488 M $ | |
+34.65% | 2 212 M $ | |
-7.72% | 1 316 M $ | |
+22.96% | 1 230 M $ | |
+107.87% | 446 M $ | |
+12.15% | 397 M $ |